COMMIT Trademark

Trademark Overview

On Friday, June 19, 2020, a trademark application was filed for COMMIT with the United States Patent and Trademark Office. The USPTO has given the COMMIT trademark a serial number of 90009820. The federal status of this trademark filing is REGISTERED as of Tuesday, April 18, 2023. This trademark is owned by Gilead Sciences, Inc.. The COMMIT trademark is filed in the Insurance & Financial Services category with the following description:

Providing grants for research in the medical and pharmaceutical fields; Providing grants for research related to infectious diseases, emerging viruses, and coronavirus
commit

General Information

Serial Number90009820
Word MarkCOMMIT
Filing DateFriday, June 19, 2020
Status700 - REGISTERED
Status DateTuesday, April 18, 2023
Registration Number7031471
Registration DateTuesday, April 18, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesProviding grants for research in the medical and pharmaceutical fields; Providing grants for research related to infectious diseases, emerging viruses, and coronavirus

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, July 18, 2020
Primary Code036
First Use Anywhere DateMonday, May 24, 2021
First Use In Commerce DateMonday, May 24, 2021

Trademark Owner History

Party NameGilead Sciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGilead Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGilead Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events

Event DateEvent Description
Tuesday, April 18, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 18, 2023REGISTERED-PRINCIPAL REGISTER
Friday, March 17, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 16, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 17, 2023USE AMENDMENT FILED
Monday, February 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 17, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 18, 2022ASSIGNED TO LIE
Friday, May 13, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 31, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, July 13, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 28, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 28, 2020LETTER OF SUSPENSION E-MAILED
Friday, August 28, 2020SUSPENSION LETTER WRITTEN
Wednesday, August 26, 2020ASSIGNED TO EXAMINER
Saturday, July 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 23, 2020NEW APPLICATION ENTERED

Related Keywords

commit research grants providing emerging coronavirus diseases viruses fields medical pharmaceutical